Canbex Therapeutics Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 4
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $109M
Latest Deal Amount

Canbex Therapeutics General Information

Description

Operator of a drug development company. The company provides cannabinoid agonists for the treatment of spasticity in multiple sclerosis and other related disorders.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Primary Office
  • London BioScience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Canbex Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Feb-2015 $109M 00.000 00000 Completed Generating Revenue
3. Grant 06-Sep-2013 00.000 Completed Generating Revenue
2. Later Stage VC (Series A) 11-Apr-2013 $4.99M $4.99M 00.000 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Canbex Therapeutics’s complete valuation and funding history, request access »

Canbex Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 000.00 000.00 00 000.00 00.000
Ordinary 2 00,000 000.00 000.00 00 000.00 0.000
Ordinary 1 172,580 $4.43 $4.43 1x $4.43 22.23%
To view Canbex Therapeutics’s complete cap table history, request access »

Canbex Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Jesse Schulman Ph.D Chief Executive Officer
David Selwood Ph.D Chief Scientific Officer & Co-Founder
Barny Cox Ph.D Director, Preclinical Operations
David Baker Head of Biology & Co-Founder
Cristina Visintin Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

Canbex Therapeutics Board Members (6)

Name Representing Role Since
Andrew Wood Self Board Member 000 0000
Keith Powell Self Chairman 000 0000
Roel Bulthuis M Ventures Board Member 000 0000
You’re viewing 3 of 6 board members. Get the full list »

Canbex Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Canbex Therapeutics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bloomsbury Bioseed Fund Venture Capital Minority 000 0000 000000 0
Esperante Ventures Corporate Venture Capital Minority 000 0000 000000 0
FastForward Innovations Venture Capital Minority 000 0000 000000 0
M Ventures Corporate Venture Capital Minority 000 0000 000000 0
UCL Business University Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »